Previous 10 | Next 10 |
SAN DIEGO, Jan. 03, 2022 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company innovating in the field of oral biotherapeutics for gastrointestinal health and beyond, today announced that the company will participate in a pre-recorded presentation at the H.C. Wainw...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Progenity (NASDAQ: PROG ) is a clinical-stage biotech company. PROG stock completed its initial public offering (IPO) in 2020 at $15 per share. Source: Mongkolchon Akesin / Shutterstock.com The company would suf...
Progenity is transitioning away from molecular testing operations to focus on the development of biotherapeutics. In this respect, the third quarter's financials were pivotal to the transformation strategy as it translated into a reduction in operational expenses as planned. With ...
SAN DIEGO, Dec. 20, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company innovating in the field of oral biotherapeutics for gastrointestinal health and beyond, today announced it has successfully closed the business divestiture of its affiliate Avero Diagnos...
Today, we are circling back on Progenity, which was a small medical diagnostic firm when we last took an in-depth look at it in January of this year. The company has completely shifted its business focus and brought in a new CEO to help with its transformation since we last posted res...
Penny Stocks to Watch as 2021 Comes to an End As 2021 comes to an end, investors continue to search for the best penny stocks to buy . Although it can be challenging given the sheer number of penny stocks out there and factors at play, there are many ways to make money with ...
3 Penny Stocks For Your Watchlist Next Year As we move closer toward the end of the year, trading penny stocks and blue chips can be difficult. With the high level of volatility we’re witnessing in the stock market, there is a lot of factors that investors need to keep track of. ...
Are These Penny Stocks on Your Watchlist Right Now? Right now, there are a sizable amount of factors for penny stocks traders to consider. And before we get into them, we have to understand why these issues matter when it comes to trading penny stocks . The easiest answer to thi...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Progenity (NASDAQ: PROG ) didn’t go public recently. Instead, its IPO dates back to June 19, 2020, when the biotech sold 6.67 million shares of PROG stock at $15 a pop. Source: Shutterstock ...
Penny Stocks With High Hopes From Analysts If you’re looking for penny stocks to buy, there are plenty of things to research. You could hunt for low float stocks, companies with news, insider trading activity, or, like we’ll look at today, penny stocks with bullish analyst...
News, Short Squeeze, Breakout and More Instantly...
Progenity Inc. Company Name:
PROG Stock Symbol:
NASDAQ Market:
Pharmacokinetic and tissue data confirm NaviCap platform delivers topically through the entire colon, with lower systemic concentrations, as desired Data modeling suggests tofacitinib tissue concentrations greater than IC90 through at least 16 hours after dosing SAN DIEGO, July 18...
SAN DIEGO, July 08, 2024 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company reimagining therapeutic delivery, today announced further details on its virtual event to be held on Wednesday, July 17, 2024. The event will feature Bruce Sands, MD, MS (Icahn School of ...
Drug-device combination leverages Biora’s NaviCap ™ platform to deliver tofacitinib directly to colonic tissue as a potential treatment for ulcerative colitis BT-600 was well tolerated and met all trial objectives, demonstrating the NaviCap platform’s ab...